The European transcatheter aortic valve implantation (TAVI) market continues to demonstrate robust growth in 2026, with an estimated market value of €4.5–5.0 billion and annual growth of 7–9%. Beyond headline growth, the market is entering a more complex phase defined by efficiency, competition, and innovation.
Emerging Players
A growing number of challengers are entering the European market. JenaValve is targeting aortic regurgitation, while Meril Life Sciences is gaining traction with cost-competitive offerings. Chinese players such as Venus Medtech and MicroPort are also expanding into Europe.
On the Ground at EuroPCR 2026
Attending ESC 2026 will provide first-hand insight into how rapidly the TAVI landscape is evolving. Conversations with clinicians and industry leaders are expected to reinforce the shift toward outpatient procedures, greater emphasis on durability, and increasing openness to evaluating new entrants. Notably, emerging players are expected to showcase technologies aimed at niche indications and cost efficiency, highlighting how competitive dynamics are beginning to move from theory to reality.
A Market Moving Beyond Expansion
TAVI adoption is now firmly established across all risk categories. Hospitals are prioritising
procedural efficiency, reduced length of stay, and improved throughput. Minimalist TAVI
approaches and same-day discharge pathways are becoming increasingly common.
Incumbent Dominance
Edwards Lifesciences and Medtronic continue to dominate the European market, supported by
deep clinical evidence and strong physician trust. Switching barriers remain high due to procedural
familiarity and risk considerations.
Pricing Pressure
Pricing dynamics are beginning to shift, particularly in cost-sensitive regions. Hospitals are
increasingly evaluating value-based procurement strategies.
Innovation Trends
Innovation is focused on durability, delivery systems, and AI-driven procedural planning, with
expansion into new indications such as aortic regurgitation.
Outlook
The EU TAVI market is evolving into a more competitive and strategically complex environment.
While incumbents remain dominant, emerging players are expected to gradually gain share in
targeted segments.